Viewing nowAliko Hydrochloride Ciprofloxacin Tablet 250 Milligrams
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

MFDS item code 199800906 · Notified 1998.01.16 · Insurance code 656001060
Treatment of genitourinary, respiratory, and head and neck infections, as well as abdominal, skin, and osteoarticular infections
This medication is effective against various bacteria such as Escherichia coli, Shigella, and Salmonella, and is used to treat respiratory infections (excluding acute bronchitis), community-acquired pneumonia, ear, nose, and throat infections, bacterial prostatitis, complicated urinary tract infections, gonococcal cervicitis and urethritis, gastrointestinal and biliary infections, skin and soft tissue infections, bone and joint infections, gynecological infections, and peritonitis. However, as a fluoroquinolone agent, it carries a risk of serious side effects, so it should only be used when there are no alternative treatments for some mild infections. This drug can be safely used for treating various infections caused by different bacteria.
(Tablets) ○ The usual adult dose of ciprofloxacin is 250 ~ 500 mg per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. Acute infections are usually treated for 5 ~ 10 days, and treatment should continue for at least 3 days after symptoms disappear. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be carefully monitored after administration. Adjust the dose appropriately according to symptoms.
This medication can cause serious side effects such as tendonitis or tendon rupture, so if such symptoms occur, use should be discontinued immediately. Additionally, it may affect peripheral neuropathy or the central nervous system, so caution is needed if neurological symptoms arise. It should not be administered to patients with myasthenia gravis, as symptoms may worsen. The risk of tendon rupture may be higher in elderly patients, patients with impaired renal function, and those taking corticosteroids together, so co-administration should be avoided. Women who are pregnant or breastfeeding, adolescents under 18 who are still growing, patients with epilepsy, and those allergic to this drug or similar drugs should not use it. This medication may increase the risk of seizures, so patients with convulsive disorders or central nervous system diseases should use it cautiously. While taking this medication, photosensitivity reactions may occur, so strong sunlight or ultraviolet exposure should be avoided, and if skin rashes or itching occur, the medication should be discontinued. Diabetics who require blood sugar control should pay attention to blood glucose fluctuations, and if hypoglycemic symptoms occur, they should consult healthcare professionals immediately. This drug has many interactions with other medications, particularly with theophylline, warfarin, tizanidine, and ketoprofen, so it is essential to consult with a physician or pharmacist. Overdose may cause renal issues, so prescribed dosage and quantity must be adhered to. Finally, this medication should be stored out of the reach of children and away from direct sunlight or ultraviolet light.
Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, decreased hemoglobin, decreased hematocrit, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reactions, shock resembling anaphylaxis, serum sickness-like reactions, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, dysgeusia, insomnia, sensory abnormalities, sensory impairment, loss of taste, tremors, convulsions, vertigo, delirium, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, vision impairment, color vision defects, diplopia, tinnitus, hearing loss, transient hearing loss, auditory damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, membrane colitis, colitis accompanied by bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, hepatic necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, erythroderma, Stevens-Johnson syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, elevated BUN, elevated serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vulvovaginal candidiasis, unexplained pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, cardiac valve regurgitation, cardiac valve insufficiency, musculoskeletal disorders, psychiatric disorders, sensory abnormalities, convulsions, increased intracranial pressure, suicidal thoughts, suicide attempts, self-harming behavior, rhabdomyolysis, muscle weakness, interstitial pneumonia, visual impairments, retinal detachment
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container, protected from air and moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.